Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15700
Abstract: Activated coagulation factor XI (FXIa) contributes to the development and propagation of thrombosis but plays only a minor role in hemostasis; therefore, it is an attractive antithrombotic target. read more here.
Keywords: profile asundexian; pharmacological profile; asundexian novel; novel orally ... See more keywords